Vault-13

Avidity Partners Management LP

DALLAS, TX · CIK 1791827 · 13F filing filed 2021-08-16

SEC-registered investment adviser since 2020 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Dallas, TX (main office)United States United Statesabout 5
New York, NYUnited States United States2

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$3.7bn reported value +3.2% vs Q1 2021
112positions
34.9%in top 10
54 new 23 added 24 reduced 35 sold out vs Q1 2021

Holdings, Q2 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 950,000 $191.5m5.18% 5.18% AddedShares held: Q3 2020 0, Q4 2020 147.3k, Q1 2021 310.9k, Q2 2021 950.0k +639.1k +639,100 205.6%
2 ABBVIE INC COM ABBV ABBV 1,484,400 $167.2m4.52% 4.52% ReducedShares held: Q3 2020 1.5m, Q4 2020 1.4m, Q1 2021 2.1m, Q2 2021 1.5m -592.8k -592,800 -28.5%
3 ARVINAS INC COM ARVN ARVN 1,854,000 $142.8m3.86% 3.86% AddedShares held: Q3 2020 1.3m, Q4 2020 1.8m, Q1 2021 1.8m, Q2 2021 1.9m +93.7k +93,700 5.3%
4 ELI LILLY & CO COM LLY LLY 565,500 $129.8m3.51% 3.51% NewShares held: Q3 2020 0, Q4 2020 810.5k, Q1 2021 0, Q2 2021 565.5k
5 MARAVAI LIFESCIENCES HLDGS I COM CL A MRVI MRVI 2,963,545 $123.7m3.34% 3.34% AddedShares held: Q3 2020 0, Q4 2020 3.4m, Q1 2021 2.8m, Q2 2021 3.0m +202.0k +202,000 7.3%
6 MIRATI THERAPEUTICS INC COM MRTX MRTX 753,000 $121.6m3.29% 3.29% AddedShares held: Q3 2020 275.0k, Q4 2020 380.0k, Q1 2021 475.7k, Q2 2021 753.0k +277.3k +277,300 58.3%
7 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 2,160,000 $114.9m3.11% 3.11% AddedShares held: Q3 2020 904.1k, Q4 2020 1.1m, Q1 2021 1.3m, Q2 2021 2.2m +896.7k +896,700 71.0%
8 AVANTOR INC COM AVTR AVTR 3,180,000 $112.9m3.05% 3.05% ReducedShares held: Q3 2020 4.6m, Q4 2020 6.6m, Q1 2021 5.0m, Q2 2021 3.2m -1.8m -1,805,100 -36.2%
9 SEAGEN INC COM SGEN SGEN 640,000 $101.0m2.73% 2.73% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 577.9k, Q2 2021 640.0k +62.1k +62,100 10.8%
10 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 882,500 $85.7m2.32% 2.32% ReducedShares held: Q3 2020 1.3m, Q4 2020 491.8k, Q1 2021 1.0m, Q2 2021 882.5k -167.3k -167,300 -15.9%
11 HOLOGIC INC COM HOLX HOLX 1,208,800 $80.7m2.18% 2.18% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.2m
12 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 4,615,000 $79.2m2.14% 2.14% AddedShares held: Q3 2020 1.9m, Q4 2020 3.3m, Q1 2021 3.8m, Q2 2021 4.6m +769.0k +769,000 20.0%
13 ESSA PHARMA INC COM NEW EPI EPI 2,750,000 $78.6m2.12% 2.12% ReducedShares held: Q3 2020 2.1m, Q4 2020 2.6m, Q1 2021 2.8m, Q2 2021 2.8m -90.0k -90,000 -3.2%
14 EXACT SCIENCES CORP COM EXAS EXAS 590,000 $73.3m1.98% 1.98% ReducedShares held: Q3 2020 0, Q4 2020 247.0k, Q1 2021 598.0k, Q2 2021 590.0k -8.0k -8,000 -1.3%
15 MEDTRONIC PLC SHS MDT MDT 535,000 $66.4m1.79% 1.79% ReducedShares held: Q3 2020 181.0k, Q4 2020 301.0k, Q1 2021 1.0m, Q2 2021 535.0k -489.2k -489,200 -47.8%
16 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 681,000 $66.3m1.79% 1.79% AddedShares held: Q3 2020 0, Q4 2020 300.0k, Q1 2021 521.4k, Q2 2021 681.0k +159.6k +159,600 30.6%
17 NUVATION BIO INC COM CL A NUVB NUVB 6,966,376 $64.9m1.75% 1.75% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 7.5m, Q2 2021 7.0m -555.6k -555,565 -7.4%
18 ARENA PHARMACEUTICALS INC COM NEW ARNA ARNA 943,000 $64.3m1.74% 1.74% AddedShares held: Q3 2020 0, Q4 2020 621.0k, Q1 2021 898.5k, Q2 2021 943.0k +44.5k +44,450 5.0%
19 BIOGEN INC COM BIIB BIIB 183,900 $63.7m1.72% 1.72% NewShares held: Q3 2020 315.1k, Q4 2020 0, Q1 2021 0, Q2 2021 183.9k
20 NEOGENOMICS INC COM NEW NEO NEO 1,367,000 $61.7m1.67% 1.67% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.4m
21 INTELLIA THERAPEUTICS INC COM NTLA NTLA 380,000 $61.5m1.66% 1.66% NewShares held: Q3 2020 0, Q4 2020 303.0k, Q1 2021 0, Q2 2021 380.0k
22 I MAB SPONSORED ADS NBP NBP 729,000 $61.2m1.65% 1.65% ReducedShares held: Q3 2020 1.3m, Q4 2020 1.6m, Q1 2021 1.3m, Q2 2021 729.0k -600.0k -600,000 -45.1%
23 CATALENT INC COM CTLT CTLT 540,000 $58.4m1.58% 1.58% ReducedShares held: Q3 2020 318.1k, Q4 2020 337.0k, Q1 2021 560.0k, Q2 2021 540.0k -20.0k -20,000 -3.6%
24 SHATTUCK LABS INC COM STTK STTK 1,940,200 $56.2m1.52% 1.52% AddedShares held: Q3 2020 0, Q4 2020 938.8k, Q1 2021 1.3m, Q2 2021 1.9m +609.8k +609,815 45.8%
25 CENTENE CORP DEL COM CNC CNC 751,200 $54.8m1.48% 1.48% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 751.2k
26 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 568,000 $53.2m1.44% 1.44% ReducedShares held: Q3 2020 930.2k, Q4 2020 1.2m, Q1 2021 581.0k, Q2 2021 568.0k -13.0k -13,000 -2.2%
27 BLUEPRINT MEDICINES CORP COM BPMC BPMC 563,200 $49.5m1.34% 1.34% AddedShares held: Q3 2020 0, Q4 2020 240.0k, Q1 2021 546.0k, Q2 2021 563.2k +17.2k +17,200 3.1%
28 NATERA INC COM NTRA NTRA 436,000 $49.5m1.34% 1.34% AddedShares held: Q3 2020 503.4k, Q4 2020 479.8k, Q1 2021 395.6k, Q2 2021 436.0k +40.4k +40,400 10.2%
29 SOTERA HEALTH CO COM SHC SHC 1,910,000 $46.3m1.25% 1.25% AddedShares held: Q3 2020 0, Q4 2020 700.0k, Q1 2021 1.2m, Q2 2021 1.9m +749.0k +749,000 64.5%
30 ACCELERON PHARMA INC COM XLRN XLRN 358,500 $45.0m1.22% 1.22% AddedShares held: Q3 2020 0, Q4 2020 299.0k, Q1 2021 322.8k, Q2 2021 358.5k +35.7k +35,700 11.1%
31 IDEAYA BIOSCIENCES INC COM IDYA IDYA 2,070,000 $43.4m1.17% 1.17% AddedShares held: Q3 2020 1.1m, Q4 2020 0, Q1 2021 1.5m, Q2 2021 2.1m +598.0k +598,000 40.6%
32 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 236,400 $42.4m1.15% 1.15% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 236.4k
33 BRIDGEBIO PHARMA INC COM BBIO BBIO 673,400 $41.0m1.11% 1.11% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 815.1k, Q2 2021 673.4k -141.7k -141,700 -17.4%
34 ALPHATEC HLDGS INC COM NEW ATEC ATEC 2,621,000 $40.2m1.09% 1.09% AddedShares held: Q3 2020 0, Q4 2020 1.9m, Q1 2021 2.3m, Q2 2021 2.6m +287.0k +287,000 12.3%
35 TRILLIUM THERAPEUTICS INC COM NEW TR TR 4,105,000 $39.8m1.08% 1.08% AddedShares held: Q3 2020 1.7m, Q4 2020 3.2m, Q1 2021 4.0m, Q2 2021 4.1m +90.0k +90,000 2.2%
36 CYTEIR THERAPEUTICS INC COM COM 1,808,394 $38.7m1.05% 1.05% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.8m
37 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 1,000,000 $38.1m1.03% 1.03% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.0m
38 CARDINAL HEALTH INC COM CAH CAH 654,200 $37.3m1.01% 1.01% ReducedShares held: Q3 2020 0, Q4 2020 808.0k, Q1 2021 1.5m, Q2 2021 654.2k -808.8k -808,800 -55.3%
39 KADMON HLDGS INC COM KDMN KDMN 9,294,600 $36.0m0.97% 0.97% ReducedShares held: Q3 2020 9.0m, Q4 2020 9.6m, Q1 2021 9.5m, Q2 2021 9.3m -249.6k -249,600 -2.6%
40 DYNAVAX TECHNOLOGIES CORP COM NEW DVAX DVAX 3,400,000 $33.5m0.91% 0.91% ReducedShares held: Q3 2020 2.0m, Q4 2020 4.0m, Q1 2021 3.5m, Q2 2021 3.4m -100.0k -100,000 -2.9%
41 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 195,000 $33.1m0.89% 0.89% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 428.0k, Q2 2021 195.0k -233.0k -232,969 -54.4%
42 INSMED INC COM PAR $.01 INSM INSM 1,150,050 $32.7m0.88% 0.88% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.2m
43 SEASPINE HLDGS CORP COM SPNE SPNE 1,524,998 $31.3m0.85% 0.85% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.5m
44 LIFESTANCE HEALTH GROUP INC COM LFST LFST 1,100,000 $30.6m0.83% 0.83% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.1m
45 CENTURY THERAPEUTICS INC COM IPSC IPSC 1,003,522 $29.4m0.80% 0.80% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.0m
46 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 625,000 $25.7m0.69% 0.69% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 625.0k
47 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 601,000 $23.5m0.63% 0.63% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 550.0k, Q2 2021 601.0k +51.0k +51,000 9.3%
48 ADICET BIO INC COM COM 2,250,500 $23.2m0.63% 0.63% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 2.2m, Q2 2021 2.3m +20.5k +20,500 0.9%
49 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 940,000 $22.9m0.62% 0.62% NewShares held: Q3 2020 0, Q4 2020 527.6k, Q1 2021 0, Q2 2021 940.0k
50 GRAPHITE BIO INC COM GRPH GRPH 735,500 $22.6m0.61% 0.61% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 735.5k
51 HARPOON THERAPEUTICS INC COM COM 1,500,000 $20.8m0.56% 0.56% AddedShares held: Q3 2020 1.2m, Q4 2020 785.0k, Q1 2021 1.4m, Q2 2021 1.5m +92.0k +92,000 6.5%
52 UIPATH INC CL A PATH PATH 300,000 $20.4m0.55% 0.55% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 300.0k
53 GRITSTONE BIO INC COM GRTS GRTS 2,122,064 $19.4m0.52% 0.52% UnchangedShares held: Q3 2020 0, Q4 2020 2.1m, Q1 2021 2.1m, Q2 2021 2.1m
54 SI-BONE INC COM SIBN SIBN 575,000 $18.1m0.49% 0.49% ReducedShares held: Q3 2020 0, Q4 2020 639.9k, Q1 2021 577.6k, Q2 2021 575.0k -2.6k -2,570 -0.4%
55 ZAI LAB LTD ADR ZLAB ZLAB 100,000 $17.7m0.48% 0.48% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 100.0k
56 ORCHARD THERAPEUTICS PLC ADS ORTX ORTX 3,781,798 $16.6m0.45% 0.45% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 4.3m, Q2 2021 3.8m -536.0k -536,002 -12.4%
57 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 1,450,000 $16.4m0.44% 0.44% ReducedShares held: Q3 2020 1.4m, Q4 2020 1.4m, Q1 2021 2.6m, Q2 2021 1.4m -1.1m -1,102,000 -43.2%
58 PHASEBIO PHARMACEUTICALS INC COM PHAS PHAS 4,315,000 $16.1m0.43% 0.43% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 4.3m, Q2 2021 4.3m +30.0k +30,000 0.7%
59 SYNEOS HEALTH INC CL A INCR INCR 175,000 $15.7m0.42% 0.42% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 175.0k
60 SANA BIOTECHNOLOGY INC COM SANA SANA 778,597 $15.3m0.41% 0.41% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 732.3k, Q2 2021 778.6k +46.3k +46,276 6.3%
61 SCYNEXIS INC COM NEW COM NEW 2,060,000 $15.2m0.41% 0.41% AddedShares held: Q3 2020 0, Q4 2020 1.3m, Q1 2021 1.3m, Q2 2021 2.1m +796.2k +796,231 63.0%
62 ALPINE IMMUNE SCIENCES INC COM NVLS NVLS 1,495,000 $13.5m0.36% 0.36% ReducedShares held: Q3 2020 810.0k, Q4 2020 1.2m, Q1 2021 1.5m, Q2 2021 1.5m -16.0k -16,000 -1.1%
63 BELLUS HEALTH INC NEW COM NEW BLU BLU 4,250,000 $13.2m0.36% 0.36% ReducedShares held: Q3 2020 0, Q4 2020 5.7m, Q1 2021 6.8m, Q2 2021 4.2m -2.5m -2,547,400 -37.5%
64 AC IMMUNE SA SHS ACIU ACIU 1,584,000 $12.6m0.34% 0.34% NewShares held: Q3 2020 1.6m, Q4 2020 0, Q1 2021 0, Q2 2021 1.6m
65 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 560,000 $12.2m0.33% 0.33% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 560.0k
66 NAUTILUS BIOTECHNOLOGY INC COM NAUT NAUT 1,125,000 $11.4m0.31% 0.31% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.1m
67 WEREWOLF THERAPEUTICS INC COM HOWL HOWL 650,265 $11.3m0.31% 0.31% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 650.3k
68 ZETA GLOBAL HOLDINGS CORP CL A ZETA ZETA 1,300,000 $10.9m0.30% 0.30% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.3m
69 CAREMAX INC COM CL A COM CL A 817,402 $10.5m0.28% 0.28% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 817.4k
70 PROTHENA CORP PLC SHS PRTA PRTA 182,000 $9.4m0.25% 0.25% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 182.0k
71 CARDIFF ONCOLOGY INC COM CRDF CRDF 1,395,000 $9.3m0.25% 0.25% ReducedShares held: Q3 2020 0, Q4 2020 1.6m, Q1 2021 2.4m, Q2 2021 1.4m -1.1m -1,052,700 -43.0%
72 MONDAY COM LTD SHS MNDY MNDY 40,000 $8.9m0.24% 0.24% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 40.0k
73 IVERIC BIO INC COM OPHT OPHT 1,400,010 $8.8m0.24% 0.24% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.4m
74 DOXIMITY INC CL A DOCS DOCS 150,000 $8.7m0.24% 0.24% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 150.0k
75 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 104,000 $8.6m0.23% 0.23% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 104.0k
76 SENTINELONE INC CL A S S 200,000 $8.5m0.23% 0.23% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 200.0k
77 ESPERION THERAPEUTICS INC NE COM ESPR ESPR 400,000 $8.5m0.23% 0.23% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 400.0k
78 ONCOSEC MED INC COM COM 2,800,000 $7.9m0.21% 0.21% ReducedShares held: Q3 2020 0, Q4 2020 2.0m, Q1 2021 3.5m, Q2 2021 2.8m -670.0k -670,000 -19.3%
79 INSTIL BIO INC COM COM 400,000 $7.7m0.21% 0.21% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 400.0k, Q2 2021 400.0k
80 VIR BIOTECHNOLOGY INC COM VIR VIR 162,000 $7.7m0.21% 0.21% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 162.0k
81 PHARVARIS N V COM PHVS PHVS 400,000 $7.5m0.20% 0.20% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 400.0k, Q2 2021 400.0k
82 CM LIFE SCIENCES INC COM CL A COM CL A 525,000 $7.4m0.20% 0.20% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 550.0k, Q2 2021 525.0k -25.0k -25,000 -4.5%
83 MONTE ROSA THERAPEUTICS INC COM GLUE GLUE 300,000 $6.8m0.18% 0.18% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 300.0k
84 DENALI THERAPEUTICS INC COM DNLI DNLI 86,100 $6.8m0.18% 0.18% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 86.1k
85 ATAI LIFE SCIENCES NV SHS ATAI ATAI 350,987 $6.5m0.18% 0.18% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 351.0k
86 TALARIS THERAPEUTICS INC COM COM 436,363 $6.4m0.17% 0.17% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 436.4k
87 ARYA SCIENCES ACQU CORP IV CL A CL A 500,000 $5.4m0.14% 0.14% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 500.0k, Q2 2021 500.0k
88 BCLS ACQUISITION CORP COM CL A COM CL A 500,000 $5.3m0.14% 0.14% UnchangedShares held: Q3 2020 0, Q4 2020 500.0k, Q1 2021 500.0k, Q2 2021 500.0k
89 MEDICUS SCIENCES ACQUISITION CL A SHS CL A SHS 520,000 $5.0m0.14% 0.14% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 520.0k
90 FIGS INC CL A FIGS FIGS 100,000 $5.0m0.14% 0.14% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 100.0k
91 PANACEA ACQUISITION CORP II CL A SHS CL A SHS 500,000 $5.0m0.14% 0.14% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 500.0k
92 DYNAMICS SPECIAL PURPOSE COR CLASS A COM CLASS A COM 500,000 $5.0m0.13% 0.13% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 500.0k
93 HEALTHCOR CATALIO ACQU CORP CL A SHS HYPR HYPR 500,000 $4.9m0.13% 0.13% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 500.0k, Q2 2021 500.0k
94 CELCUITY INC COM CELC CELC 200,000 $4.8m0.13% 0.13% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 200.0k
95 CONFLUENT INC CLASS A COM CFLT CFLT 100,000 $4.8m0.13% 0.13% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 100.0k
96 CM LIFE SCIENCES II INC UNIT 02/25/2028 UNIT 02/25/2028 330,000 $4.4m0.12% 0.12% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 336.7k, Q2 2021 330.0k -6.7k -6,700 -2.0%
97 WALKME LTD ORD SHS ORD SHS 150,000 $4.4m0.12% 0.12% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 150.0k
98 HELIX ACQUISITION CORP COM CL A MLTX MLTX 400,000 $4.1m0.11% 0.11% UnchangedShares held: Q3 2020 0, Q4 2020 400.0k, Q1 2021 400.0k, Q2 2021 400.0k
99 HEALTH SCIENCES ACQ CORP 2 ORD SHS OBIO OBIO 400,000 $4.1m0.11% 0.11% UnchangedShares held: Q3 2020 400.0k, Q4 2020 400.0k, Q1 2021 400.0k, Q2 2021 400.0k
100 LIFESCI ACQUISITION II CORP COM COM 400,000 $4.0m0.11% 0.11% UnchangedShares held: Q3 2020 0, Q4 2020 400.0k, Q1 2021 400.0k, Q2 2021 400.0k

Sold out since Q1 2021

SecurityTickerShares held beforeValue then
ASTRAZENECA PLC 3,650,500 $181.5m3.7m shares
INTUITIVE SURGICAL INC ISRG ISRG 139,400 $103.0m139.4k shares
BAUSCH HEALTH COS INC BHC BHC 1,891,300 $60.0m1.9m shares
ZIMMER BIOMET HOLDINGS INC ZBH ZBH 326,000 $52.2m326.0k shares
CHEMOCENTRYX INC CCXI CCXI 940,800 $48.2m940.8k shares
ABIOMED INC ABMD ABMD 132,500 $42.2m132.5k shares
INOVIO PHARMACEUTICALS INC 4,004,391 $37.2m4.0m shares
THE CIGNA GROUP CI CI 135,000 $32.6m135.0k shares
ATHIRA PHARMA INC 1,677,845 $30.9m1.7m shares
CULLINAN THERAPEUTICS INC CGEM CGEM 707,359 $29.5m707.4k shares
ORGANOGENESIS HLDGS INC ORGO ORGO 1,463,403 $26.7m1.5m shares
KINIKSA PHARMACEUTICALS LTD 1,330,700 $24.6m1.3m shares
CURIS INC 2,053,789 $23.2m2.1m shares
AURINIA PHARMACEUTICALS INC AUPH AUPH 1,784,000 $23.2m1.8m shares
IGM BIOSCIENCES INC IGMS IGMS 293,000 $22.5m293.0k shares
BOLT BIOTHERAPEUTICS INC 654,294 $21.5m654.3k shares
CHIMERIX INC CMRX CMRX 2,230,000 $21.5m2.2m shares
BIOVENTUS INC BVS BVS 1,254,333 $19.2m1.3m shares
SIGILON THERAPEUTICS INC 850,968 $19.0m851.0k shares
COLLEGIUM PHARMACEUTICAL INC COLL COLL 740,000 $17.5m740.0k shares
KEZAR LIFE SCIENCES INC 1,907,081 $11.4m1.9m shares
ADAMAS PHARMACEUTICALS INC ADMS ADMS 2,200,200 $10.6m2.2m shares
AFFIMED N V 1,296,000 $10.3m1.3m shares
MERUS N V MRUS MRUS 487,000 $10.2m487.0k shares
IMMATICS N.V IMTX IMTX 884,600 $9.9m884.6k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
IMMUNIC INC 13G · filed 2026-04-17 9.9% +5.1 pts 13G 2026-04-17
CONTEXT THERAPEUTICS INC CNTX · 13G · filed 2026-05-12 CNTX 8.7%≈ $4.6m -1.2 pts 13G 2026-05-12
PERSPECTIVE THERAPEUTICS INC CATX · 13G · filed 2026-03-10 CATX 5.3%≈ $20.6m +1.1 pts 13G 2026-03-10